氮芥凝胶局部治疗蕈样肉芽肿型皮肤T细胞淋巴瘤的临床潜力：当前疗效和安全性数据综述
Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data.
作者信息
Liner Kendall, Brown Celeste, McGirt Laura Y
机构信息
Division of Dermatology, Medical College of Georgia at Augusta Health, Augusta, GA, USA.
School of Medicine, University of North Carolina at Chapel Hill, Carolinas Medical Center, Charlotte, NC, USA.
出版信息
Drug Des Devel Ther. 2018 Jan 31;12:241-254. doi: 10.2147/DDDT.S137106. eCollection 2018.
Abstract
Nitrogen mustard is a chemotherapeutic agent that has a well-documented safety and efficacy profile in the treatment of cutaneous T-cell lymphoma. Development of nitrogen mustard formulations and treatment regimens has been studied extensively over the last 40 years. In the last 5 years, a new gel formulation has been developed that is associated with a decrease in delayed hypersensitivity reactions. The authors in this review found that while the gel formulation may result in a decrease of allergic contact dermatitis, this advantage has been replaced by a higher number of irritant contact reactions and a decrease in complete response rate. The gel formulation has a complete response rate of 13.8%, which is a decrease in efficacy when compared to aqueous-based preparations of similar concentrations.
摘要
氮芥是一种化疗药物，在治疗皮肤T细胞淋巴瘤方面有着充分记录的安全性和有效性。在过去40年里，对氮芥制剂和治疗方案的研发进行了广泛研究。在过去5年中，开发出了一种新的凝胶制剂，其与迟发型超敏反应的减少有关。该综述的作者发现，虽然凝胶制剂可能会导致过敏性接触性皮炎减少，但这一优势已被更多的刺激性接触反应和完全缓解率的降低所取代。凝胶制剂的完全缓解率为13.8%，与类似浓度的水性制剂相比，其疗效有所降低。
相似文献
1
Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data.氮芥凝胶局部治疗蕈样肉芽肿型皮肤T细胞淋巴瘤的临床潜力：当前疗效和安全性数据综述
Drug Des Devel Ther. 2018 Jan 31;12:241-254. doi: 10.2147/DDDT.S137106. eCollection 2018.
2
Mechlorethamine gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma.氮芥凝胶用于IA期和IB期蕈样肉芽肿型皮肤T细胞淋巴瘤的局部治疗。
Expert Rev Clin Pharmacol. 2014 Sep;7(5):591-7. doi: 10.1586/17512433.2014.944500. Epub 2014 Jul 28.
3
Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides.皮肤 T 细胞淋巴瘤的局部化疗：一项新型氮芥，0.02%，凝胶治疗蕈样肉芽肿的疗效和安全性的随机、对照、多中心试验的阳性结果。
JAMA Dermatol. 2013 Jan;149(1):25-32. doi: 10.1001/2013.jamadermatol.541.
4
Real-world experience with mechlorethamine gel in patients with mycosis fungoides-cutaneous lymphoma: Preliminary findings from a prospective observational study.氮芥凝胶治疗蕈样肉芽肿型皮肤淋巴瘤患者的真实世界经验：一项前瞻性观察研究的初步结果
J Am Acad Dermatol. 2020 Sep;83(3):928-930. doi: 10.1016/j.jaad.2019.12.070. Epub 2020 Feb 20.
5
A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas. French Study Group of Cutaneous Lymphomas.皮肤T细胞淋巴瘤患者对局部氮芥疗法皮肤不耐受的前瞻性研究。法国皮肤淋巴瘤研究小组。
Arch Dermatol. 1999 Nov;135(11):1349-53. doi: 10.1001/archderm.135.11.1349.
6
In brief: mechlorethamine gel (Valchlor) for cutaneous T-Cell lymphoma.简而言之：用于皮肤T细胞淋巴瘤的氮芥凝胶（Valchlor）。
Med Lett Drugs Ther. 2015 Apr 27;57(1467):e66.
7
The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma.PROVe 研究：氯苯丁二氮䓬/美法仑凝胶联合其他疗法治疗蕈样肉芽肿皮肤 T 细胞淋巴瘤患者的美国真实世界经验。
Am J Clin Dermatol. 2021 May;22(3):407-414. doi: 10.1007/s40257-021-00591-x. Epub 2021 Mar 3.
8
Management of Mycosis Fungoides with Topical Chlormethine/Mechlorethamine Gel: A Columbia University Cutaneous Lymphoma Center Experience.氯苯丁二氮卓/美法仑凝胶治疗蕈样肉芽肿：哥伦比亚大学皮肤淋巴瘤中心的经验。
Acta Derm Venereol. 2021 Sep 8;101(9):adv00544. doi: 10.2340/00015555-3911.
9
Nitrogen mustard gel-induced inflammation triggers lymphomatoid papulosis in patients with mycosis fungoides.氮芥凝胶诱导炎症引发蕈样肉芽肿患者的淋巴瘤样丘疹病。
J Dermatol. 2020 May;47(5):546-550. doi: 10.1111/1346-8138.15276. Epub 2020 Feb 26.
10
Optimizing Care and Compliance for the Treatment of Mycosis Fungoides Cutaneous T-Cell Lymphoma With Mechlorethamine Gel.用氮芥凝胶优化蕈样肉芽肿性皮肤T细胞淋巴瘤治疗的护理与依从性
Clin J Oncol Nurs. 2015 Dec;19(6):E131-9. doi: 10.1188/15.CJON.E131-E139.
引用本文的文献
1
The Novel Achievements in Oncological Metabolic Radio-Therapy: Isotope Technologies, Targeted Theranostics, Translational Oncology Research.肿瘤代谢放射治疗的新成就：同位素技术、靶向诊疗学、转化肿瘤学研究
Med Sci (Basel). 2025 Aug 1;13(3):107. doi: 10.3390/medsci13030107.
2
A practical and safer model of nitrogen mustard injury in cornea.一种实用且更安全的角膜氮芥损伤模型。
PLoS One. 2025 Jul 3;20(7):e0327622. doi: 10.1371/journal.pone.0327622. eCollection 2025.
3
Nitrogen mustard induces dynamic nuclear protein spectrum change and DNA-protein crosslinking, with p97 mediating repair.氮芥诱导动态核蛋白谱变化和DNA-蛋白质交联，p97介导修复。
Heliyon. 2024 Sep 4;10(17):e37401. doi: 10.1016/j.heliyon.2024.e37401. eCollection 2024 Sep 15.
4
Immunosequencing applications in cutaneous T-cell lymphoma.免疫测序在皮肤 T 细胞淋巴瘤中的应用。
Front Immunol. 2023 Dec 21;14:1300061. doi: 10.3389/fimmu.2023.1300061. eCollection 2023.
5
Multidisciplinary Approach to the Diagnosis and Therapy of Mycosis Fungoides.蕈样肉芽肿诊断与治疗的多学科方法
Healthcare (Basel). 2023 Feb 18;11(4):614. doi: 10.3390/healthcare11040614.
6
Harnessing the immune system in the treatment of cutaneous T cell lymphomas.利用免疫系统治疗皮肤T细胞淋巴瘤。
Front Oncol. 2023 Jan 12;12:1071171. doi: 10.3389/fonc.2022.1071171. eCollection 2022.
7
Gene Regulations upon Hydrogel-Mediated Drug Delivery Systems in Skin Cancers-An Overview.皮肤癌中基于水凝胶的药物递送系统的基因调控——综述
Gels. 2022 Sep 2;8(9):560. doi: 10.3390/gels8090560.
8
How we treat mycosis fungoides and Sézary syndrome.我们如何治疗蕈样肉芽肿和塞扎里综合征。
Clin Adv Hematol Oncol. 2021 Sep;19(9):573-581.
9
Post hoc Analysis of a Randomized, Controlled, Phase 2 Study to Assess Response Rates with Chlormethine/Mechlorethamine Gel in Patients with Stage IA-IIA Mycosis Fungoides.一项评估氯氨丁乙氧氮芥凝胶治疗 I 期至 IIA 期蕈样肉芽肿患者应答率的随机、对照、2 期研究的事后分析。
Dermatology. 2022;238(2):347-357. doi: 10.1159/000516138. Epub 2021 Jun 4.
10
C6 Ceramide (d18:1/6:0) as a Novel Treatment of Cutaneous T Cell Lymphoma.C6神经酰胺（d18:1/6:0）作为皮肤T细胞淋巴瘤的一种新型治疗方法。
Cancers (Basel). 2021 Jan 13;13(2):270. doi: 10.3390/cancers13020270.
本文引用的文献
1
Mechlorethamine gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma.氮芥凝胶用于IA期和IB期蕈样肉芽肿型皮肤T细胞淋巴瘤的局部治疗。
Expert Rev Clin Pharmacol. 2014 Sep;7(5):591-7. doi: 10.1586/17512433.2014.944500. Epub 2014 Jul 28.
2
Secondary cancers, comorbidities and mortality associated with nitrogen mustard therapy in patients with mycosis fungoides: a 30-year population-based cohort study.蕈样肉芽肿患者氮芥治疗相关的继发性癌症、合并症和死亡率：一项基于人群的 30 年队列研究。
Br J Dermatol. 2014 Mar;170(3):699-704. doi: 10.1111/bjd.12620.
3
Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides.皮肤 T 细胞淋巴瘤的局部化疗：一项新型氮芥，0.02%，凝胶治疗蕈样肉芽肿的疗效和安全性的随机、对照、多中心试验的阳性结果。
JAMA Dermatol. 2013 Jan;149(1):25-32. doi: 10.1001/2013.jamadermatol.541.
4
Topical nitrogen mustard therapy in patients with mycosis fungoides or parapsoriasis.蕈样肉芽肿或类银屑病患者的局部氮芥治疗。
J Eur Acad Dermatol Venereol. 2013 Feb;27(2):163-8. doi: 10.1111/j.1468-3083.2011.04433.x. Epub 2012 Jan 9.
5
Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC).蕈样肉芽肿和塞扎里综合征分期与分类的修订：国际皮肤淋巴瘤协会（ISCL）和欧洲癌症研究与治疗组织（EORTC）皮肤淋巴瘤特别工作组的提议
Blood. 2007 Sep 15;110(6):1713-22. doi: 10.1182/blood-2007-03-055749. Epub 2007 May 31.
6
Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective study.每周两次应用氮芥和外用皮质类固醇治疗早期蕈样肉芽肿：一项前瞻性研究。
Arch Dermatol. 2005 Sep;141(9):1117-20. doi: 10.1001/archderm.141.9.1117.
7
Topical nitrogen mustard in the management of mycosis fungoides: update of the Stanford experience.局部用氮芥治疗蕈样肉芽肿：斯坦福大学经验的更新
Arch Dermatol. 2003 Feb;139(2):165-73. doi: 10.1001/archderm.139.2.165.
8
Treatment of cutaneous T cell lymphoma: current status and future directions.皮肤T细胞淋巴瘤的治疗：现状与未来方向
Am J Clin Dermatol. 2002;3(3):193-215. doi: 10.2165/00128071-200203030-00006.
9
Ointment-based mechlorethamine treatment for mycosis fungoides.
Cancer. 1983 Dec 15;52(12):2214-9. doi: 10.1002/1097-0142(19831215)52:12<2214::aid-cncr2820521207>3.0.co;2-h.
10
Response of mycosis fungoides to topical chemotherapy with mechlorethamine.蕈样肉芽肿对氮芥局部化疗的反应。
Arch Dermatol. 1984 Dec;120(12):1585-90.
Zotero 插件